Valeo Financial Advisors, LLC Intercept Pharmaceuticals, Inc. Transaction History

Valeo Financial Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 28, 2020	SELL	$39.09 - $53.44 $96,747 - $132,264	-2,475 Closed	0 $0
Q1 2020 Apr 13, 2020	SELL	$48.35 - $118.68 $51,976 - $127,581	-1,075 Reduced 30.28%	2,475 $171,000
Q4 2019 Jan 24, 2020	BUY	$57.36 - $124.1 $197,892 - $428,145	3,450 Added 3450.0%	3,550 $440,000
Q4 2018 Jan 30, 2019	SELL	$85.79 - $126.46 $857 - $1,264	-10 Reduced 9.09%	100 $10,000
Q3 2018 Nov 01, 2018	BUY	$88.49 - $127.55 $9,733 - $14,030	110 New	110 $10,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Valeo Financial Advisors, LLC with notifications on news.